Xin Lang Cai Jing·2026-01-12 15:13Core Viewpoint - WuXi AppTec (603259.SH) has released an earnings forecast for 2025 that exceeds its previously raised guidance, indicating strong revenue and net profit growth driven by its integrated CRDMO model and non-recurring gains from asset disposals [1] Group 1: Financial Performance - The company expects to achieve a total revenue of 45.456 billion yuan in 2025, representing a year-on-year increase of 15.84%, with core business revenue growing approximately 21.40% [1] - Adjusted net profit attributable to shareholders is projected to be 14.957 billion yuan, reflecting a year-on-year growth of about 41.33%, while net profit attributable to the company’s shareholders is expected to reach 19.151 billion yuan, marking a significant increase of approximately 102.65% [1] - The company has raised its annual revenue guidance for the second time within a year, adjusting the expected range from 42.5-43.5 billion yuan to 43.5-44 billion yuan [1] Group 2: Business Segments - The TIDES business (oligonucleotides and peptide drugs) has shown remarkable performance, with revenue reaching 7.84 billion yuan in the first three quarters, a year-on-year increase of 121.1%, setting historical highs for both the first three quarters and the third quarter [2] - Non-recurring gains from asset disposals have significantly contributed to the earnings exceeding expectations, with net gains from the sale of certain equity stakes totaling 5.595 billion yuan, accounting for 37.41% of the expected annual net profit [2] Group 3: Strategic Focus - The company is focusing on its core CRDMO areas by divesting from clinical research services, which has resulted in a gain of 1.434 billion yuan from the sale of related businesses [2] - WuXi AppTec is expanding its global footprint with ongoing construction of overseas bases in Singapore and Delaware, aiming to mitigate geopolitical risks and better meet customer demands [3] - Revenue from U.S. clients has reached 22.15 billion yuan in the first three quarters of 2025, reflecting a year-on-year growth of 31.9% and increasing its share of total revenue to 67%, becoming a key growth driver [3]